Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry

Haemophilia. 2015 Mar;21(2):e122-e124. doi: 10.1111/hae.12590. Epub 2015 Jan 27.

Authors

R Kruse-Jarres¹, A Gilsenan², J Spears³, J A Kaye²

Affiliations

¹ Puget Sound Blood Center, Seattle, WA, USA.
² RTI Health Solutions, Research Triangle Park, NC, USA.
³ Grifols, Research Triangle Park, NC, USA.

PMID: 25623889
DOI: 10.1111/hae.12590

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Drug Combinations
Factor VIII / adverse effects
Factor VIII / immunology
Factor VIII / therapeutic use*
Hemophilia A / diagnosis
Hemophilia A / drug therapy*
Hemophilia A / immunology*
Humans
Immune Tolerance*
Isoantibodies / immunology
Registries
Treatment Outcome
von Willebrand Factor / adverse effects
von Willebrand Factor / therapeutic use*

Substances

Drug Combinations
Isoantibodies
factor VIII, von Willebrand factor drug combination
von Willebrand Factor
Factor VIII